Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Bier, S; Sim, A; Balbay, D; Todenhöfer, T; Aufderklamm, S; Halalsheh, O; Mischinger, J; Böttge, J; Rausch, S; Stenzl, A; Gakis, G; Canda, E; Schwentner, C.
Treatment of invasive bladder cancer: robot-assisted radical cystectomy and intracorporeal urinary diversion].
Urologe A. 2015; 54(1):41-46
Doi: 10.1007/s00120-014-3702-2
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Mischinger Johannes
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Robot-assisted radical cystectomy (RARC) and intracorporeal urinary diversion are only performed in a few centers of excellence worldwide. Functional and oncologic outcomes are comparable. We report on our experience with RARC and intracorporeal diversion. We retrospectively identified 86 RARCs in 72 men and 14 women (mean age 69.7 years). All patients underwent robot-assisted radical cystectomy and pelvic lymphadenectomy followed by intracorporeal urinary diversion using ileal conduit or neobladder. Of the 86 patients, 24 patients (28%) underwent intracorporeal ileal conduit and 62 patients (72%) underwent intracorporeal neobladder formation. A Studer pouch was created in all who underwent intracorporeal neobladder diversion. Cancer specific survival (CSS) and overall survival (OS) are reported. The mean operative time was 418.9 min (range 205-690 min) and blood loss was 380 ml (range 100-1000 ml). The mean hospital stay was 17.5 days (range 5-62 days). All the surgeries were completed with no open conversions. Minor complications (grade I and II) were reported in 23 patients, while major complications (grade III and above) were reported in 21 patients. The mean nodal yield was 20.3 (range 0-46). Positive margins were found in in 8%. The average follow-up was 31.5 months (range 3-52 months). Continence could be achieved in 88% of patients who received an intracorporeal neobladder. The cancer-specific survival (CSS) and overall survival (OS) were 80% and 70%, respectively. RARC with intracorporeal diversion seems to be safe and reproducible in tertiary centers with robotic expertise. Operative times are acceptable and complications as well as functional and oncologic outcomes are comparable. Further standardization of RARC with intracorporeal diversion may lead to a wider adoption of the approach.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Aged -
- Aged, 80 and over -
- Cystectomy - mortality
- Female -
- Female - epidemiology
- Humans -
- Lymph Node Excision -
- Male -
- Middle Aged -
- Neoplasm Invasiveness -
- Prevalence -
- Retrospective Studies -
- Risk Factors -
- Robotic Surgical Procedures - mortality
- Survival Rate -
- Treatment Outcome -
- Urinary Bladder Neoplasms - mortality
- Urinary Bladder Neoplasms - pathology
- Urinary Bladder Neoplasms - therapy
- Urinary Diversion - mortality
- Find related publications in this database (Keywords)
- Radical cystectomy
- Neobladder
- Ileal conduit
- Intracorporeal diversion
- Lymphadenectomy